slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
31,2 TWD | +1,46% | -0,32% | +4,17% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
New Drug Translation Development Services
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -82,89% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -82,89% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hai Shan Jian
CEO | Chief Executive Officer | - | 31-07-13 |
Wen Chi Lee
FOU | Founder | - | 31-07-13 |
Fu Pin Wu
DFI | Director of Finance/CFO | - | 21-04-22 |
Shu Yueh Lin
COO | Chief Operating Officer | - | 01-03-22 |
Hui Ling Chang
IRC | Investor Relations Contact | - | 15-04-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ta Kun Shih
BRD | Director/Board Member | 72 | 15-03-22 |
Hsiu Lien Lin
BRD | Director/Board Member | - | 15-03-22 |
Hai Shan Jian
CEO | Chief Executive Officer | - | 31-07-13 |
Wen Chi Lee
FOU | Founder | - | 31-07-13 |
Liang Sheng Kan
BRD | Director/Board Member | - | 15-03-22 |
Hui Chin Tseng
BRD | Director/Board Member | - | 15-03-22 |
Yueh Hsuan Chan
BRD | Director/Board Member | - | 15-03-22 |
Meng Pin Tseng
BRD | Director/Board Member | - | 15-03-22 |
Te Hsing Hu
BRD | Director/Board Member | - | 15-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 115 754 000 | 115 754 000 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
BRIM Biotechnology, Inc.
8/F 1, Alley 30, Lane 358, Ruiguang Road
114036, Taipei
+
http://www.brimbiotech.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,17% | 111 mln. | |
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. |
- Beurs
- Aandelen
- Koers 6885
- Onderneming BRIM Biotechnology, Inc.